These data show an upregulation of CD155 (PVR) and CD73 (NT5E) in GBM, compared with normal tissue and that co-expression of CD155 and CD73 acts as a negative prognostic factor in GBM (Fig. 1A, B, Supplementary Fig. 1). The gene discussed is PVR; the disease is glioblastoma.